{"schema_version":"secwatch.filing_event.v1","accession":"0001472375-21-000139","form_type":"8-K","ticker":"RGPX","cik":"0001357878","company_name":"REGENEREX PHARMA, INC.","filed_at":"2021-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.236348+00:00","generated_at":"2026-06-28T06:28:10.799381+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Peptide Technologies names Gregory Pilant CEO/Chairman, Deborah Pilant Secretary/Treasurer","bullets":["Gregory P. Pilant appointed CEO and Chairman of the Board effective Nov 16, 2021; Deborah L. Pilant appointed Secretary/Treasurer.","Dennis Cox and Irene Getty resigned from Board of Directors effective Nov 16, 2021.","Bruce Sellars resigned as CEO but remains on Board; Byron Striloff resigned as President effective Nov 16, 2021.","Dr. Lee Ori appointed as Chief Operating Officer effective Nov 16, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001472375-21-000139","json":"https://secwatch.observer/filing/0001472375-21-000139.json","markdown":"https://secwatch.observer/filing/0001472375-21-000139.md","text":"https://secwatch.observer/filing/0001472375-21-000139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/ixform8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:28:10.799381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"459374fe59","claim":"Dennis Cox resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"},{"claim_id":"4813ea22a9","claim":"Deborah L. Pilant was appointed as Secretary/Treasurer at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective November 16, 2021, Ms. Deborah L. Pilant has been appointed to serve as Secretary/Treasurer of the Company for the coming year.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Secretary/Treasurer"}],"fact_type":"executive_change"},{"claim_id":"618cf7af91","claim":"Bruce Sellars resigned as Chief Executive Officer at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective November 16, 2021, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"6ebb8be1c4","claim":"Dr. Lee Ori was appointed as Chief Operating Officer at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective November 16, 2021, Dr. Lee Ori has been appointed to serve as Chief Operating Officer of the Company for the coming year.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"7f406d49e4","claim":"Gregory P. Pilant was appointed as Chief Executive Officer and Chairman of the Board at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective November 16, 2021, Mr. Gregory P. Pilant has been appointed to serve as Chief Executive Officer and Chairman of the Board for the Company for the coming year.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer and Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"9e32d22698","claim":"Irene Getty resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"},{"claim_id":"d9ef3b8126","claim":"Byron Striloff resigned as President at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective November 16, 2021, Byron Striloff tendered his letter of resignation to the Company resigning from his position as President of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}